Get the Stockscreener App
312.50
2.00%
-6.39
Pre-market:
312.41
-0.09
-0.03%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $312.50, with a volume of 3.07M.
It is down -2.00% in the last 24 hours and up +5.91% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$318.89
Open:
$311.39
24h Volume:
3.07M
Relative Volume:
1.00
Market Cap:
$167.64B
Revenue:
$33.42B
Net Income/Loss:
$4.09B
P/E Ratio:
41.39
EPS:
7.55
Net Cash Flow:
$10.39B
1W Performance:
-1.29%
1M Performance:
+5.91%
6M Performance:
-5.32%
1Y Performance:
+13.00%
1-Day Range:
$308.64
$316.02
1-Week Range:
$308.64
$335.88
52-Week Range:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
312.50 | 167.64B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
821.86 | 781.10B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
212.06 | 374.36B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
162.85 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
74.79 | 332.00B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
93.35 | 251.88B | 64.17B | 17.12B | 18.10B | 6.73 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
OFI Invest Asset Management Makes New $1.43 Million Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Machina Capital S.A.S. - MarketBeat
Amgen (NASDAQ:AMGN) Stock Acquired Rep. Jefferson Shreve - MarketBeat
Sowell Financial Services LLC Sells 1,036 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Banco Santander S.A. Cuts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PNC Financial Services Group Inc. Sells 21,757 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
William Blair Comments on Amgen's Q4 Earnings (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Bank Julius Baer & Co. Ltd Zurich - MarketBeat
Meriwether Wealth & Planning LLC Purchases Shares of 1,601 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's Options: A Look at What the Big Money is Thinking - Benzinga
Shining a Light on Multiple Myeloma: Insights from an Expert - Amgen
Amgen Inc. (AMGN): Among Dobermans of the Dow to Buy - Yahoo Finance
Minimal Residual Disease Market Expected to rise, 2032 | Adaptive Biotechnologies, Bristol-Myers Squibb Company, Natera, Kite Pharma, Amgen Inc., expected to boost the market - Barchart
Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide - GlobeNewswire Inc.
Securian Asset Management Inc. Trims Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Hopwood Financial Services Inc. Takes $418,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Summit X LLC Takes $455,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Saturna Capital Corp Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Sequoia Financial Advisors LLC - MarketBeat
AGF Management Ltd. Sells 60,774 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Moors & Cabot Inc. Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Pzena Investment Management LLC Invests $209,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
River Road Asset Management LLC Has $10.65 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
14,720 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Generali Investments CEE investicni spolecnost a.s. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Lifeworks Advisors LLC - MarketBeat
William Blair Comments on Amgen's Q1 Earnings (NASDAQ:AMGN) - MarketBeat
Amundi Reduces Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Arjuna Capital Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Andra AP fonden Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
HM Payson & Co. Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
11 Best Pharma Stocks to Buy According to Hedge Funds - Insider Monkey
Kyowa Kirin, Amgen’s rocatinlimab ignites positive response in Rocket study - BioWorld Online
Cushing Capital Partners LLC Invests $635,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Founders Financial Alliance LLC Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Miller Financial Services LLC Buys New Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cornerstone Advisors LLC Buys 1,300 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
King Luther Capital Management Corp Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,778 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Riverbend Wealth Management LLC - MarketBeat
Moran Wealth Management LLC Has $6.15 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Independent Advisor Alliance - MarketBeat
Callan Family Office LLC Has $3.64 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Edgestream Partners L.P. Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Destination Wealth Management Invests $386,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Townsend Asset Management Corp NC ADV Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Naviter Wealth LLC Purchases 1,791 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
(03/11/25) AMGN: A Big Pharma Name Bucking the Bearish Market Trend - Moneyshow.com
Candriam S.C.A. Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen, Fresenius Settle Osteoporosis Drug Patent Dispute - Law360
Samsung, Celltrion lead biosimilar market in Europe, US - Korea Economic Daily
Amgen: Riding The MariTide Of Monthly Weight Loss (NASDAQ:AMGN) - Seeking Alpha
Amgen : Update on Patent Litigation Related to Fresenius Denosumab Biosimilar Products - Marketscreener.com
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):